Edition:
India

Evoke Pharma Inc (EVOK.OQ)

EVOK.OQ on NASDAQ Stock Exchange Capital Market

1.50USD
1:30am IST
Change (% chg)

$-0.03 (-1.96%)
Prev Close
$1.53
Open
$1.55
Day's High
$1.63
Day's Low
$1.48
Volume
134,242
Avg. Vol
39,393
52-wk High
$3.40
52-wk Low
$1.05

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.089
Jun '18 0.00 -0.140
Mar '18 0.00 -0.129
FY 2017 Dec '17 0.00 -0.020
Sep '17 0.00 -0.342
Jun '17 0.00 -0.106
Mar '17 0.00 -0.373
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-19 2 17.18 18.82 15.54 35.33
Year Ending Dec-20 2 61.09 90.06 32.13 73.81
Earnings (per share)
Quarter Ending Mar-19 1 -0.06 -0.06 -0.06 -0.13
Quarter Ending Jun-19 1 -0.06 -0.06 -0.06 -0.13
Year Ending Dec-19 2 -0.62 -0.29 -0.95 -0.11
Year Ending Dec-20 2 0.87 1.89 -0.15 0.44
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 29.30 32.54
P/E High - Last 5 Yrs. -- 43.23 48.15
P/E Low - Last 5 Yrs. -- 22.71 23.42
Beta 1.24 0.86 0.87
Price to Sales (TTM) -- 6.59 8.39
Price to Book (MRQ) 8.23 5.12 5.27
Price to Tangible Book (MRQ) 8.23 5.84 6.74
Price to Cash Flow (TTM) -- 23.07 24.12
% Owned Institutions 32.02 0.87 1.65

Dividends

  Company industry sector
Dividend Yield -- 1.43 1.35
Dividend Yield - 5 Year Avg -- 1.45 1.37
Dividend 5 Year Growth Rate -- 3.99 4.70
Payout Ratio(TTM) -- 42.18 39.60

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 5.43 13.45
Sales (TTM) vs TTM 1 Yr. Ago -- 6.61 8.02
Sales - 5 Yr. Growth Rate -- 10.48 10.85
EPS (MRQ) vs Qtr. 1 Yr. Ago 74.25 45.67 47.68
EPS (TTM) vs TTM 1 Yr. Ago 46.19 -- --
EPS - 5 Yr. Growth Rate -- 9.91 10.47
Capital Spending - 5 Yr. Growth Rate -- 15.26 14.68

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.07 2.18
Current Ratio (MRQ) 7.00 2.87 2.98
LT Debt to Equity (MRQ) 0.00 8.87 11.35
Total Debt to Equity (MRQ) 0.00 12.87 16.02
Interest Coverage (TTM) -38.00 32.47 28.44

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 52.10 52.41
Gross Margin - 5 Yr. Avg. -- 49.66 50.39
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 17.26 12.43
Operating Margin (TTM) -- 13.53 5.77
Operating Margin - 5 Yr. Avg. -- 13.69 8.02
Pre-Tax Margin (TTM) -- 11.90 4.80
Pre-Tax Margin - 5 Yr. Avg. -- 14.11 8.31
Net Profit Margin (TTM) -- 8.81 1.53
Net Profit Margin - 5 Yr. Avg. -- 10.60 4.72
Effective Tax Rate (TTM) -- 22.12 22.13
Effective Tax Rate - 5 Yr. Avg. -- 22.26 22.58

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 928,329,244 820,307,647
Net Income/Employee (TTM) -1,604,376 105,132,028 92,854,588
Receivable Turnover (TTM) -- 5.84 5.82
Inventory Turnover (TTM) -- 2.57 3.41
Asset Turnover (TTM) 0.00 0.93 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -126.24 10.98 10.60
Return on Assets - 5 Yr. Avg. -74.54 12.41 11.78
Return on Investment (TTM) -230.38 14.23 13.82
Return on Investment - 5 Yr. Avg. -86.15 16.18 15.32
Return on Equity (TTM) -428.40 15.46 15.25
Return on Equity - 5 Yr. Avg. -565.58 17.07 16.41
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 38.41 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Evoke Pharma Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 27.92 23.50 94 31
13 Week 39.77 32.96 93 42
26 Week 23.55 14.16 83 45
52 Week 65.30 40.10 87 9
YTD 79.21 57.38 92 37
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 30.35%
# of Holders: 24
Total Shares Held: 5,289,438
3 Mo. Net Change: 455,502
# New Positions: 3
# Closed Positions: 8
# Increased Positions: 8
# Reduced Positions: 10
# Net Buyers: -2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.